Trademark: 98589121
Word
CTX340
Status
Pending
Status Code
630
Status Date
Thursday, June 6, 2024
Serial Number
98589121
Mark Type
4
Filing Date
Thursday, June 6, 2024

Trademark Owner History

Classifications
5 Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of renal and cardiovascular diseases or conditions; pharmaceutical and biopharmaceutical agents for the treatment of renal and cardiovascular diseases or conditions in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of renal and cardiovascular diseases or conditions in the field of in vivo gene editing therapy
42 Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy

Trademark Events
Jun 6, 2024
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24